FDA Approves Single-Dose Aprepitant Regimen for MEC
The FDA has expanded the approval of aprepitant (Cinvanti) injectable emulsion for intravenous use to include the 130-mg single-dose regimen for patients receiving moderately epigenetic chemotherapy.
Source: OncLive